HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums fiscal 2007

This article was originally published in The Rose Sheet

Executive Summary

Firm records net sales of $389.6 mil. for 2007, up 21% from a year ago. Results reflect strong sales of Burberry fragrances, which brought in $210 mil. for the year, according to March 10 release. Sales in Europe totaled $330.8 mil., representing 85% of consolidated sales overall. In North America, sales rose 15% to $58.8 mil. due to Inter Parfums' specialty retail business with Gap, Banana Republic and New York & Company. Net income for the year was $23.8 mil. Inter Parfums is preparing busy launch schedule for 2008, including new scents for Burberry, Roxy, Quicksilver, Van Cleef & Arpels and S.T. Dupont. Rumeur 2 Rose is "being readied" for introduction under firm's Lanvin Brand, and limited-edition Paul Smith men's and women's scents also are on the way, according to Chairman of the Board and CEO Jean Madar. "As did many of our peers, we entered the fourth quarter of 2007 with much trepidation, and looked to contain costs and brace for a turbulent holiday season. With fourth quarter sales far exceeding our expectations, fourth quarter profits came in considerably better than anticipated," Madar says. Company announced fourth-quarter results in February (1"The Rose Sheet" Feb. 4, 2008, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015305

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel